Archives: Agenda

Improving clinical trial representation to increase access to trials

  • Sharing best practices for recruiting and integrating populations that are not well represented in oncology trials
  • Lessons from Advancing Inclusive Research Site Alliance collaborations
  • What strategies that pharma/biotech and vendor companies can design and support to help sites reach a more diverse patient population

Transforming Patient Engagement in Clinical Trials: The Power of Gamification

The success of clinical trials is critically dependent on consistent patient participation, yet challenges in engagement continue to extend study timelines and drive escalating costs. This educational session delves into gamification as an innovative and scientifically validated method to enhance patient retention and improve protocol adherence throughout the clinical research lifecycle.

Gamification, the strategic integration of behavioral science principles with interactive elements, motivates sustained patient engagement, directly addressing participant dropout and non-compliance. By deploying thoughtfully designed incentive structures and compelling engagement mechanisms, clinical research teams can notably elevate data quality, expedite study timelines, and reduce associated costs.

This presentation explores three foundational dimensions of gamification within clinical research: its theoretical underpinnings, rationale for implementation, and demonstrated effectiveness in real-world trial environments. Attendees will benefit from:

·       Insight into psychological and behavioral drivers of sustained patient motivation

·       Practical strategies and best practices for incorporating gamified elements into clinical trials

·       Real-world case studies showcasing measurable improvements in participant retention and compliance

Good Clinical Practice and Bioethics

• Put the theory into practice: from patient information to Informed Consent
• Real application of bioethics autonomy principle.
• Training in Good Clinical Practices: where we want to go

Medical monitoring done right: the three questions every sponsor should ask

Ensuring the right medical monitoring (MM) approach is critical to trial success—but sponsors often overlook key factors that impact cost, efficiency, and patient safety. This session will cover three essential questions sponsors should ask: Who is on the medical team and do they have real-world expertise? Are you paying for the right level of MM or just paying more? When should MM start, and what happens if it’s too late? Attendees will gain actionable insights on how to optimize MM strategy, avoid unnecessary expenses, and enhance study outcomes.

 

·       Medical monitoring teams: Why indication-specific expertise matters.

·       Cost versus value: Avoiding unnecessary 24/7 coverage and eligibility review costs.

·       Early MM involvement: How proactive planning prevents protocol pitfalls.